Last reviewed · How we verify

Iodixanol(Drug) — Competitive Intelligence Brief

Iodixanol(Drug) (Iodixanol(Drug)) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iso-osmolar contrast medium (IOCM). Area: Diagnostic Imaging.

marketed Iso-osmolar contrast medium (IOCM) Diagnostic Imaging Small molecule Live · refreshed every 30 min

Target snapshot

Iodixanol(Drug) (Iodixanol(Drug)) — Seoul National University Hospital. Iodixanol is a non-ionic, iso-osmolar contrast medium that provides radiographic visualization of blood vessels and body cavities by absorbing X-rays.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Iodixanol(Drug) TARGET Iodixanol(Drug) Seoul National University Hospital marketed Iso-osmolar contrast medium (IOCM)
Iodixanol 320 mgI/mL Iodixanol 320 mgI/mL Guerbet marketed Iso-osmolar contrast medium (IOCM)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iso-osmolar contrast medium (IOCM) class)

  1. Guerbet · 1 drug in this class
  2. Seoul National University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Iodixanol(Drug) — Competitive Intelligence Brief. https://druglandscape.com/ci/iodixanol-drug. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: